Ferrous Citrate


Combined with:

Lansoprazole
Lasix
Prednisolone

Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 31.7%
Prophylaxis Against Transplant Rejection 13.1%
Anxiety 8.7%
Product Used For Unknown Indication 6.0%
Anaemia Prophylaxis 4.9%
Gastritis Prophylaxis 4.9%
Hypertension 3.3%
Pulmonary Arterial Hypertension 3.3%
Antibiotic Prophylaxis 2.7%
Anal Fissure 2.2%
Cerebral Infarction 2.2%
Gastritis 2.2%
Hypercholesterolaemia 2.2%
Insomnia 2.2%
Osteoporosis 2.2%
Osteoporosis Prophylaxis 2.2%
Anaemia 1.6%
Dementia Alzheimer's Type 1.6%
Prophylaxis 1.6%
Bronchiectasis 1.1%
Cervical Spinal Stenosis 8.0%
False Positive Laboratory Result 8.0%
Gastric Cancer 8.0%
Pyrexia 8.0%
Uterine Cancer 8.0%
Altered State Of Consciousness 4.0%
Anaemia 4.0%
Arthritis Bacterial 4.0%
Blood Cortisol Decreased 4.0%
Blood Immunoglobulin G Decreased 4.0%
Erythema Multiforme 4.0%
Exostosis 4.0%
Hepatic Cirrhosis 4.0%
Interstitial Lung Disease 4.0%
Multi-organ Failure 4.0%
Pyelonephritis 4.0%
Renal Impairment 4.0%
Unresponsive To Stimuli 4.0%
Visual Field Defect 4.0%
Vomiting 4.0%
Concomitant
Rheumatoid Arthritis 14.2%
Prophylaxis 13.8%
Hypertension 10.2%
Product Used For Unknown Indication 9.9%
Crohn's Disease 7.0%
Anaemia 6.3%
Colitis Ulcerative 4.6%
Iron Deficiency Anaemia 4.5%
Metastatic Renal Cell Carcinoma 3.9%
Constipation 3.7%
Drug Use For Unknown Indication 2.9%
Colorectal Cancer 2.6%
Diabetes Mellitus 2.4%
Osteoporosis 2.3%
Insomnia 2.2%
Gastritis 2.1%
Pain 2.0%
Atrial Fibrillation 2.0%
Hepatitis C 1.8%
Renal Cell Carcinoma 1.7%
Anaemia 10.5%
Interstitial Lung Disease 8.0%
Pyrexia 8.0%
White Blood Cell Count Decreased 7.6%
Platelet Count Decreased 7.3%
Decreased Appetite 5.8%
Cardiac Failure 5.5%
Diarrhoea 5.5%
Death 4.7%
Pancytopenia 4.4%
Pneumonia 4.0%
Neutrophil Count Decreased 3.6%
Tachycardia 3.6%
Haemorrhage Subcutaneous 3.3%
Renal Impairment 3.3%
Vomiting 3.3%
Anal Abscess 2.9%
C-reactive Protein Increased 2.9%
Hepatic Function Abnormal 2.9%
Infection 2.9%

Drug Data